Shares of Lam Research Corporation (NASDAQ:LRCX - Get Free Report) rose 7.7% on Wednesday . The stock traded as high as $297.87 and last traded at $297.17. Approximately 14,534,845 shares changed hands during trading, an increase of 30% from the average daily volume of 11,207,672 shares. The stock had previously closed at $275.80.
More Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Quarterly beat and strong June-quarter outlook — Lam reported March-quarter revenue of $5.84B and non‑GAAP EPS $1.47 (above estimates) and gave a June-quarter guide implying another step-up in wafer‑fab demand, which directly supports revenue and margin upside. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
- Positive Sentiment: New/raised analyst coverage — Seaport Global initiated coverage with a Buy and several firms have raised targets recently (median targets moved higher), which supports investor sentiment and price targets. Seaport Global initiates coverage of Lam Research (LRCX) with buy recommendation
- Positive Sentiment: Broad AI infrastructure demand is lifting the semiconductor equipment group — ETFs tracking semiconductors (SOXX, SMH, FTXL) are drawing flows as hyperscalers and chipmakers scale AI fabs, a tailwind for Lam’s order book. Semiconductor Leaders SOXX, SMH, and FTXL Are Crushing It on AI Infrastructure Demand
- Positive Sentiment: Industry capacity constraints reinforce pricing/near‑term demand — reports on KLA and other equipment suppliers running near full capacity suggest lead times and tool intensity are high, which benefits Lam as customers accelerate purchases for AI/advanced nodes. KLA’s AI Capacity Constraints Highlight Earnings Power And Buyback Commitment
- Positive Sentiment: Technical/flow signals — Lam was featured as IBD’s Stock of the Day and cleared a buy point after the beat-and-raise, which can attract momentum and retail/quant flows. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
- Neutral Sentiment: Insider selling disclosed — an SVP sold ~18,170 shares under a prearranged Rule 10b5‑1 plan; filing is standard but worth noting for transparency. Insider Selling: Lam Research NASDAQ: LRCX SVP Sells 18,170 Shares of Stock
- Neutral Sentiment: Analyst write-ups and rally analysis provide context but vary in bias — several bullish deep dives and rally analyses highlight upside from WFE upgrades, while some coverage is promotional; treat such pieces as color rather than hard catalysts. Lam Research (LRCX) Surges to Record Highs: Analyzing the 252% Rally
- Negative Sentiment: Valuation caution — some analysts/commentary warn Lam is approaching frothy levels after the run, which raises risk of near‑term mean reversion if growth expectations moderate. Lam Research Is Approaching Frothy Levels
Analysts Set New Price Targets
LRCX has been the subject of a number of recent analyst reports. Wells Fargo & Company boosted their price objective on Lam Research from $290.00 to $320.00 and gave the company an "overweight" rating in a research report on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft upped their price target on Lam Research from $300.00 to $325.00 and gave the company a "buy" rating in a research note on Thursday, April 23rd. Berenberg Bank upped their price target on Lam Research from $265.00 to $335.00 and gave the company a "buy" rating in a research note on Thursday, April 23rd. UBS Group set a $300.00 target price on Lam Research in a research note on Thursday, January 29th. Finally, Citic Securities increased their price target on Lam Research from $165.00 to $275.00 and gave the company a "buy" rating in a research report on Friday, January 30th. Twenty-six equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $285.94.
Read Our Latest Stock Analysis on Lam Research
Lam Research Stock Up 7.7%
The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.77 and a current ratio of 2.54. The business has a 50-day simple moving average of $236.99 and a two-hundred day simple moving average of $202.86. The company has a market capitalization of $371.63 billion, a price-to-earnings ratio of 56.07, a PEG ratio of 2.14 and a beta of 1.81.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.11. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The firm had revenue of $5.84 billion during the quarter, compared to analysts' expectations of $5.70 billion. During the same period in the previous year, the firm posted $1.04 earnings per share. Lam Research's revenue was up 23.8% on a year-over-year basis. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, equities analysts predict that Lam Research Corporation will post 5.68 EPS for the current year.
Insiders Place Their Bets
In other Lam Research news, SVP Neil J. Fernandes sold 18,170 shares of the business's stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $255.14, for a total transaction of $4,635,893.80. Following the completion of the sale, the senior vice president owned 66,129 shares of the company's stock, valued at approximately $16,872,153.06. The trade was a 21.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 6,010 shares of the business's stock in a transaction dated Monday, April 27th. The stock was sold at an average price of $258.66, for a total value of $1,554,546.60. Following the transaction, the insider owned 53,205 shares in the company, valued at approximately $13,762,005.30. This represents a 10.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 155,066 shares of company stock worth $35,849,242 in the last three months. Company insiders own 0.31% of the company's stock.
Institutional Trading of Lam Research
Several hedge funds and other institutional investors have recently bought and sold shares of LRCX. PMV Capital Advisers LLC bought a new position in shares of Lam Research during the fourth quarter valued at approximately $25,000. Stance Capital LLC bought a new position in shares of Lam Research during the third quarter valued at approximately $26,000. Bayban bought a new position in shares of Lam Research during the fourth quarter valued at approximately $26,000. Vermillion Wealth Management Inc. bought a new position in shares of Lam Research during the first quarter valued at approximately $26,000. Finally, Cedar Mountain Advisors LLC grew its holdings in Lam Research by 242.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock worth $26,000 after buying an additional 85 shares in the last quarter. 84.61% of the stock is owned by institutional investors.
About Lam Research
(
Get Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.